Clinical Research Directory
Browse clinical research sites, groups, and studies.
iTBS for Acute Ischemic Stroke After Thrombectomy
Sponsor: Yi Yang
Summary
The goal of this randomized, single-blind, parallel-controlled clinical trial is to evaluate the efficacy and safety of intermittent theta burst stimulation (iTBS) as an adjunctive therapy for acute anterior circulation ischemic stroke patients who have undergone successful mechanical thrombectomy (MT). The study population includes adults aged 18-85 with NIHSS scores 5-25 post-MT and eTICI≥2b reperfusion.
Official title: Efficacy and Safety of Intermittent Theta Burst Stimulation in Acute Anterior Circulation Ischemic Stroke Patients Undergoing Mechanical Thrombectomy
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
178
Start Date
2025-04-25
Completion Date
2026-08-01
Last Updated
2025-04-30
Healthy Volunteers
No
Conditions
Interventions
intermittent theta burst stimulation
The iTBS delivered to the ipsilesional primary motor cortex (M1) at 80% resting motor threshold (RMT). Each session consists of 600 pulses (3-minute trains of 50 Hz triplets repeated every 10 seconds, twice daily with a 5-minute interval), administered for 7 consecutive days starting within 6 hours post-randomization.
sham intermittent theta burst stimulation
Sham-iTBS is performed in the same way as the treatment group but uses 20% RMT.
Locations (1)
The First Hospital of Jilin University
Changchun, Jilin, China